Loading…

Photic regulation of heme oxygenase activity in the golden hamster retina: involvement of dopamine

The photic regulation of heme oxygenase (HO) activity was examined in the golden hamster retina. This enzymatic activity was significantly higher at midday than at midnight. When the hamsters were placed under constant darkness for 48 h and killed at subjective day or at subjective night, the differ...

Full description

Saved in:
Bibliographic Details
Published in:Journal of neurochemistry 2003-04, Vol.85 (2), p.534-542
Main Authors: Sacca, Geraldine B., Sáenz, Daniel A., Jaliffa, Carolina O., Minces, Luciana, Sarmiento, María I. Keller, Rosenstein, Ruth E.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5427-9d3ce129415eeedfb4b8051db6e038670973b91d335e9036690506ec10bdd44d3
cites cdi_FETCH-LOGICAL-c5427-9d3ce129415eeedfb4b8051db6e038670973b91d335e9036690506ec10bdd44d3
container_end_page 542
container_issue 2
container_start_page 534
container_title Journal of neurochemistry
container_volume 85
creator Sacca, Geraldine B.
Sáenz, Daniel A.
Jaliffa, Carolina O.
Minces, Luciana
Sarmiento, María I. Keller
Rosenstein, Ruth E.
description The photic regulation of heme oxygenase (HO) activity was examined in the golden hamster retina. This enzymatic activity was significantly higher at midday than at midnight. When the hamsters were placed under constant darkness for 48 h and killed at subjective day or at subjective night, the differences in HO activity disappeared. Western blot analysis showed no differences in HO levels among these time points. Dopamine significantly increased this activity in retinas excised at noon or at midnight, with a higher sensitivity at night. The effect of dopamine was reversed by SCH 23390 but not by spiperone and clozapine and it was not reproduced by quinpirole. In vitro, the increase in HO activity found in retinas incubated under light for 1 h was significantly reduced by SCH 23390. Two cAMP analogs increased HO activity and their effect, as well as the effect of dopamine was blocked by H‐89, a protein kinase A (PKA) inhibitor. Tin protoporphyrin IX, an HO inhibitor, significantly decreased cGMP accumulation with maximal effects during the day. Low concentrations of bilirubin decreased retinal thiobarbituric acid substances levels (an index of lipid peroxidation) in basal conditions and after exposing retinal cells to H2O2. These results suggest that hamster retinal HO activity is regulated by the photic stimulus, probably through a dopamine/cAMP/PKA dependent pathway.
doi_str_mv 10.1046/j.1471-4159.2003.01697.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73171294</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18920648</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5427-9d3ce129415eeedfb4b8051db6e038670973b91d335e9036690506ec10bdd44d3</originalsourceid><addsrcrecordid>eNqNkc2u0zAQhS0E4pYLr4C8gV3COHbsGIkFqvjVFbCAteXYk9ZVEpc4Le3b49CKu4SVR5rvHI_OIYQyKBkI-WpXMqFYIVitywqAl8CkVuXpAVn9XTwkK4CqKjiI6oY8SWkHmRKSPSY3rJKq1hxWpP22jXNwdMLNobdziCONHd3igDSezhscbUJq3RyOYT7TMNJ5i3QTe48j3dohzThl7RxG-zpvj7E_Zuk4LyY-7u0QRnxKHnW2T_js-t6SH-_ffV9_LO6-fvi0fntXuFpUqtCeO2SVzrcjou9a0TZQM99KBN5IBVrxVjPPeY0auJQaapDoGLTeC-H5LXl58d1P8ecB02yGkBz2vR0xHpJRnKnF_58ga3QFUjQZbC6gm2JKE3ZmP4XBTmfDwCxFmJ1Z8jZL3mYpwvwpwpyy9Pn1j0M7oL8XXpPPwIsrYJOzfTfZ0YV0zwmpa8Vl5t5cuF-hx_N_H2A-f1kvE_8NGlykIQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18920648</pqid></control><display><type>article</type><title>Photic regulation of heme oxygenase activity in the golden hamster retina: involvement of dopamine</title><source>Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)</source><source>Free Full-Text Journals in Chemistry</source><creator>Sacca, Geraldine B. ; Sáenz, Daniel A. ; Jaliffa, Carolina O. ; Minces, Luciana ; Sarmiento, María I. Keller ; Rosenstein, Ruth E.</creator><creatorcontrib>Sacca, Geraldine B. ; Sáenz, Daniel A. ; Jaliffa, Carolina O. ; Minces, Luciana ; Sarmiento, María I. Keller ; Rosenstein, Ruth E.</creatorcontrib><description>The photic regulation of heme oxygenase (HO) activity was examined in the golden hamster retina. This enzymatic activity was significantly higher at midday than at midnight. When the hamsters were placed under constant darkness for 48 h and killed at subjective day or at subjective night, the differences in HO activity disappeared. Western blot analysis showed no differences in HO levels among these time points. Dopamine significantly increased this activity in retinas excised at noon or at midnight, with a higher sensitivity at night. The effect of dopamine was reversed by SCH 23390 but not by spiperone and clozapine and it was not reproduced by quinpirole. In vitro, the increase in HO activity found in retinas incubated under light for 1 h was significantly reduced by SCH 23390. Two cAMP analogs increased HO activity and their effect, as well as the effect of dopamine was blocked by H‐89, a protein kinase A (PKA) inhibitor. Tin protoporphyrin IX, an HO inhibitor, significantly decreased cGMP accumulation with maximal effects during the day. Low concentrations of bilirubin decreased retinal thiobarbituric acid substances levels (an index of lipid peroxidation) in basal conditions and after exposing retinal cells to H2O2. These results suggest that hamster retinal HO activity is regulated by the photic stimulus, probably through a dopamine/cAMP/PKA dependent pathway.</description><identifier>ISSN: 0022-3042</identifier><identifier>EISSN: 1471-4159</identifier><identifier>DOI: 10.1046/j.1471-4159.2003.01697.x</identifier><identifier>PMID: 12675930</identifier><identifier>CODEN: JONRA9</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Animals ; Benzazepines - pharmacology ; Bilirubin - pharmacology ; Biological and medical sciences ; Bucladesine - pharmacology ; Circadian Rhythm - physiology ; Clozapine - pharmacology ; Cricetinae ; Cyclic AMP-Dependent Protein Kinases - antagonists &amp; inhibitors ; Cyclic AMP-Dependent Protein Kinases - metabolism ; Cyclic GMP - metabolism ; dopamine ; Dopamine - metabolism ; Dopamine - pharmacology ; Dopamine Agonists - pharmacology ; Dopamine Antagonists - pharmacology ; Enzyme Activation - drug effects ; Enzyme Inhibitors - pharmacology ; Eye and associated structures. Visual pathways and centers. Vision ; Fundamental and applied biological sciences. Psychology ; golden hamster ; heme oxygenase ; Heme Oxygenase (Decyclizing) - antagonists &amp; inhibitors ; Heme Oxygenase (Decyclizing) - metabolism ; In Vitro Techniques ; Male ; Mesocricetus ; Mesocricetus auratus ; photic regulation ; Photoperiod ; Quinpirole - pharmacology ; retina ; Retina - drug effects ; Retina - enzymology ; Retina - metabolism ; Spiperone - pharmacology ; Thiobarbituric Acid Reactive Substances - metabolism ; Vertebrates: nervous system and sense organs</subject><ispartof>Journal of neurochemistry, 2003-04, Vol.85 (2), p.534-542</ispartof><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5427-9d3ce129415eeedfb4b8051db6e038670973b91d335e9036690506ec10bdd44d3</citedby><cites>FETCH-LOGICAL-c5427-9d3ce129415eeedfb4b8051db6e038670973b91d335e9036690506ec10bdd44d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14695736$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12675930$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sacca, Geraldine B.</creatorcontrib><creatorcontrib>Sáenz, Daniel A.</creatorcontrib><creatorcontrib>Jaliffa, Carolina O.</creatorcontrib><creatorcontrib>Minces, Luciana</creatorcontrib><creatorcontrib>Sarmiento, María I. Keller</creatorcontrib><creatorcontrib>Rosenstein, Ruth E.</creatorcontrib><title>Photic regulation of heme oxygenase activity in the golden hamster retina: involvement of dopamine</title><title>Journal of neurochemistry</title><addtitle>J Neurochem</addtitle><description>The photic regulation of heme oxygenase (HO) activity was examined in the golden hamster retina. This enzymatic activity was significantly higher at midday than at midnight. When the hamsters were placed under constant darkness for 48 h and killed at subjective day or at subjective night, the differences in HO activity disappeared. Western blot analysis showed no differences in HO levels among these time points. Dopamine significantly increased this activity in retinas excised at noon or at midnight, with a higher sensitivity at night. The effect of dopamine was reversed by SCH 23390 but not by spiperone and clozapine and it was not reproduced by quinpirole. In vitro, the increase in HO activity found in retinas incubated under light for 1 h was significantly reduced by SCH 23390. Two cAMP analogs increased HO activity and their effect, as well as the effect of dopamine was blocked by H‐89, a protein kinase A (PKA) inhibitor. Tin protoporphyrin IX, an HO inhibitor, significantly decreased cGMP accumulation with maximal effects during the day. Low concentrations of bilirubin decreased retinal thiobarbituric acid substances levels (an index of lipid peroxidation) in basal conditions and after exposing retinal cells to H2O2. These results suggest that hamster retinal HO activity is regulated by the photic stimulus, probably through a dopamine/cAMP/PKA dependent pathway.</description><subject>Animals</subject><subject>Benzazepines - pharmacology</subject><subject>Bilirubin - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Bucladesine - pharmacology</subject><subject>Circadian Rhythm - physiology</subject><subject>Clozapine - pharmacology</subject><subject>Cricetinae</subject><subject>Cyclic AMP-Dependent Protein Kinases - antagonists &amp; inhibitors</subject><subject>Cyclic AMP-Dependent Protein Kinases - metabolism</subject><subject>Cyclic GMP - metabolism</subject><subject>dopamine</subject><subject>Dopamine - metabolism</subject><subject>Dopamine - pharmacology</subject><subject>Dopamine Agonists - pharmacology</subject><subject>Dopamine Antagonists - pharmacology</subject><subject>Enzyme Activation - drug effects</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Eye and associated structures. Visual pathways and centers. Vision</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>golden hamster</subject><subject>heme oxygenase</subject><subject>Heme Oxygenase (Decyclizing) - antagonists &amp; inhibitors</subject><subject>Heme Oxygenase (Decyclizing) - metabolism</subject><subject>In Vitro Techniques</subject><subject>Male</subject><subject>Mesocricetus</subject><subject>Mesocricetus auratus</subject><subject>photic regulation</subject><subject>Photoperiod</subject><subject>Quinpirole - pharmacology</subject><subject>retina</subject><subject>Retina - drug effects</subject><subject>Retina - enzymology</subject><subject>Retina - metabolism</subject><subject>Spiperone - pharmacology</subject><subject>Thiobarbituric Acid Reactive Substances - metabolism</subject><subject>Vertebrates: nervous system and sense organs</subject><issn>0022-3042</issn><issn>1471-4159</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNqNkc2u0zAQhS0E4pYLr4C8gV3COHbsGIkFqvjVFbCAteXYk9ZVEpc4Le3b49CKu4SVR5rvHI_OIYQyKBkI-WpXMqFYIVitywqAl8CkVuXpAVn9XTwkK4CqKjiI6oY8SWkHmRKSPSY3rJKq1hxWpP22jXNwdMLNobdziCONHd3igDSezhscbUJq3RyOYT7TMNJ5i3QTe48j3dohzThl7RxG-zpvj7E_Zuk4LyY-7u0QRnxKHnW2T_js-t6SH-_ffV9_LO6-fvi0fntXuFpUqtCeO2SVzrcjou9a0TZQM99KBN5IBVrxVjPPeY0auJQaapDoGLTeC-H5LXl58d1P8ecB02yGkBz2vR0xHpJRnKnF_58ga3QFUjQZbC6gm2JKE3ZmP4XBTmfDwCxFmJ1Z8jZL3mYpwvwpwpyy9Pn1j0M7oL8XXpPPwIsrYJOzfTfZ0YV0zwmpa8Vl5t5cuF-hx_N_H2A-f1kvE_8NGlykIQ</recordid><startdate>200304</startdate><enddate>200304</enddate><creator>Sacca, Geraldine B.</creator><creator>Sáenz, Daniel A.</creator><creator>Jaliffa, Carolina O.</creator><creator>Minces, Luciana</creator><creator>Sarmiento, María I. Keller</creator><creator>Rosenstein, Ruth E.</creator><general>Blackwell Science Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>200304</creationdate><title>Photic regulation of heme oxygenase activity in the golden hamster retina: involvement of dopamine</title><author>Sacca, Geraldine B. ; Sáenz, Daniel A. ; Jaliffa, Carolina O. ; Minces, Luciana ; Sarmiento, María I. Keller ; Rosenstein, Ruth E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5427-9d3ce129415eeedfb4b8051db6e038670973b91d335e9036690506ec10bdd44d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Animals</topic><topic>Benzazepines - pharmacology</topic><topic>Bilirubin - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Bucladesine - pharmacology</topic><topic>Circadian Rhythm - physiology</topic><topic>Clozapine - pharmacology</topic><topic>Cricetinae</topic><topic>Cyclic AMP-Dependent Protein Kinases - antagonists &amp; inhibitors</topic><topic>Cyclic AMP-Dependent Protein Kinases - metabolism</topic><topic>Cyclic GMP - metabolism</topic><topic>dopamine</topic><topic>Dopamine - metabolism</topic><topic>Dopamine - pharmacology</topic><topic>Dopamine Agonists - pharmacology</topic><topic>Dopamine Antagonists - pharmacology</topic><topic>Enzyme Activation - drug effects</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Eye and associated structures. Visual pathways and centers. Vision</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>golden hamster</topic><topic>heme oxygenase</topic><topic>Heme Oxygenase (Decyclizing) - antagonists &amp; inhibitors</topic><topic>Heme Oxygenase (Decyclizing) - metabolism</topic><topic>In Vitro Techniques</topic><topic>Male</topic><topic>Mesocricetus</topic><topic>Mesocricetus auratus</topic><topic>photic regulation</topic><topic>Photoperiod</topic><topic>Quinpirole - pharmacology</topic><topic>retina</topic><topic>Retina - drug effects</topic><topic>Retina - enzymology</topic><topic>Retina - metabolism</topic><topic>Spiperone - pharmacology</topic><topic>Thiobarbituric Acid Reactive Substances - metabolism</topic><topic>Vertebrates: nervous system and sense organs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sacca, Geraldine B.</creatorcontrib><creatorcontrib>Sáenz, Daniel A.</creatorcontrib><creatorcontrib>Jaliffa, Carolina O.</creatorcontrib><creatorcontrib>Minces, Luciana</creatorcontrib><creatorcontrib>Sarmiento, María I. Keller</creatorcontrib><creatorcontrib>Rosenstein, Ruth E.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of neurochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sacca, Geraldine B.</au><au>Sáenz, Daniel A.</au><au>Jaliffa, Carolina O.</au><au>Minces, Luciana</au><au>Sarmiento, María I. Keller</au><au>Rosenstein, Ruth E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Photic regulation of heme oxygenase activity in the golden hamster retina: involvement of dopamine</atitle><jtitle>Journal of neurochemistry</jtitle><addtitle>J Neurochem</addtitle><date>2003-04</date><risdate>2003</risdate><volume>85</volume><issue>2</issue><spage>534</spage><epage>542</epage><pages>534-542</pages><issn>0022-3042</issn><eissn>1471-4159</eissn><coden>JONRA9</coden><abstract>The photic regulation of heme oxygenase (HO) activity was examined in the golden hamster retina. This enzymatic activity was significantly higher at midday than at midnight. When the hamsters were placed under constant darkness for 48 h and killed at subjective day or at subjective night, the differences in HO activity disappeared. Western blot analysis showed no differences in HO levels among these time points. Dopamine significantly increased this activity in retinas excised at noon or at midnight, with a higher sensitivity at night. The effect of dopamine was reversed by SCH 23390 but not by spiperone and clozapine and it was not reproduced by quinpirole. In vitro, the increase in HO activity found in retinas incubated under light for 1 h was significantly reduced by SCH 23390. Two cAMP analogs increased HO activity and their effect, as well as the effect of dopamine was blocked by H‐89, a protein kinase A (PKA) inhibitor. Tin protoporphyrin IX, an HO inhibitor, significantly decreased cGMP accumulation with maximal effects during the day. Low concentrations of bilirubin decreased retinal thiobarbituric acid substances levels (an index of lipid peroxidation) in basal conditions and after exposing retinal cells to H2O2. These results suggest that hamster retinal HO activity is regulated by the photic stimulus, probably through a dopamine/cAMP/PKA dependent pathway.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>12675930</pmid><doi>10.1046/j.1471-4159.2003.01697.x</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-3042
ispartof Journal of neurochemistry, 2003-04, Vol.85 (2), p.534-542
issn 0022-3042
1471-4159
language eng
recordid cdi_proquest_miscellaneous_73171294
source Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list); Free Full-Text Journals in Chemistry
subjects Animals
Benzazepines - pharmacology
Bilirubin - pharmacology
Biological and medical sciences
Bucladesine - pharmacology
Circadian Rhythm - physiology
Clozapine - pharmacology
Cricetinae
Cyclic AMP-Dependent Protein Kinases - antagonists & inhibitors
Cyclic AMP-Dependent Protein Kinases - metabolism
Cyclic GMP - metabolism
dopamine
Dopamine - metabolism
Dopamine - pharmacology
Dopamine Agonists - pharmacology
Dopamine Antagonists - pharmacology
Enzyme Activation - drug effects
Enzyme Inhibitors - pharmacology
Eye and associated structures. Visual pathways and centers. Vision
Fundamental and applied biological sciences. Psychology
golden hamster
heme oxygenase
Heme Oxygenase (Decyclizing) - antagonists & inhibitors
Heme Oxygenase (Decyclizing) - metabolism
In Vitro Techniques
Male
Mesocricetus
Mesocricetus auratus
photic regulation
Photoperiod
Quinpirole - pharmacology
retina
Retina - drug effects
Retina - enzymology
Retina - metabolism
Spiperone - pharmacology
Thiobarbituric Acid Reactive Substances - metabolism
Vertebrates: nervous system and sense organs
title Photic regulation of heme oxygenase activity in the golden hamster retina: involvement of dopamine
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-23T02%3A42%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Photic%20regulation%20of%20heme%20oxygenase%20activity%20in%20the%20golden%20hamster%20retina:%20involvement%20of%20dopamine&rft.jtitle=Journal%20of%20neurochemistry&rft.au=Sacca,%20Geraldine%20B.&rft.date=2003-04&rft.volume=85&rft.issue=2&rft.spage=534&rft.epage=542&rft.pages=534-542&rft.issn=0022-3042&rft.eissn=1471-4159&rft.coden=JONRA9&rft_id=info:doi/10.1046/j.1471-4159.2003.01697.x&rft_dat=%3Cproquest_cross%3E18920648%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5427-9d3ce129415eeedfb4b8051db6e038670973b91d335e9036690506ec10bdd44d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=18920648&rft_id=info:pmid/12675930&rfr_iscdi=true